References
- Peman J, Canton E, Gobernado M and the Spanish ECMM Working Group on Candidemia. Epidemiology and antifungal susceptibility of Candida species isolates from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005; 24: 23–30.
- Wisplinghoff H, Bischoff T, Tallent SM, . Nosocomial bloodsteam infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–317.
- Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
- Pfaller MA, Diekema DJ. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Rev 2004; 10: 11–23.
- Tavanti A, Davidson AD, Gow NAR, Maiden MCJ, Odds FC. Candida orthopsilosis and Candida metapsilosis sp nov. to replace C. parapsilosis Group II and III. J Clin Microbiol 2005; 43: 284–292.
- Diekema DJ, Messer SA, Hollis RJ, . A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diagn Microbiol Infect Dis 2009; 63: 233–236.
- Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2000; 2: 73–85.
- Cheung C, Guo Y, Gialanella P, Feldmesser M. Development of candidemia on caspofungin therapy: a case report. Infection 2006; 34: 345–348.
- Clinical and Laboratory Standards Institute (formerly NCCLS). Reference method for antifungal disk diffusion susceptibility testing of yeasts: Approved standard M44-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
- Hobson RP. The global epidemiology of invasive Candida infections – is the tide turning? J Hosp Infect 2003; 55: 159–168.
- Metwally L, Walker MJ, Coyle PV, . Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001–2006. J Infect 2007; 55: 174–178.
- Sendid B, Cotteau A, Francois N, . Candidemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible link. BMC Infect Dis 2006; 6: 80. doi: 10.1186/1471-2334-4-80.
- Swinne D, Nolard N, Van Rooij P, Detandt M. Bloodstream yeast infections: a 15-month survey. Epidemiol Infect 2009; 1: 1–4.
- Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 2006; 49: 134–138.
- Forrest GN, Weekes E, Johnson JK. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 2008; 56: 126–129.
- Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in a Tertiary Care Hospital. J Clin Microbiol 2009; 47: 2392–2397.
- Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol 2008; 46: 2659–2664.